Genetic variants of CDH13 determine the susceptibility to chronic obstructive pulmonary disease in a Chinese population

Acta Pharmacologica Sinica

Volumn 37, Issue 3, 2016, Pages 390-397

  Yuan, Yi Ming ^a   Zhang, Jin Long ^a   Xu, Si Cheng ^b   Ye, Ren Song ^c   Xu, Dan ^a   Zhang, You ^a   Zhang, Yan Jie ^a   Chen, Yu Long ^a   Liu, Yu Lan ^a   Su, Zhi Guang ^a  

^a SICHUAN UNIVERSITY   (China)

^b XINJIANG MEDICAL UNIVERSITY   (China)

^c SHANGHAI EIGHTH PEOPLE'S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CADHERIN; H-CADHERIN;

ADULT; ALLELE; ARTICLE; AUTOSOMAL INHERITANCE; CDH13 GENE; CHINESE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DOMINANT INHERITANCE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HAPLOTYPE MAP; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MAXIMUM LIKELIHOOD METHOD; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CHINA; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; LUNG; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

ADIPONECTIN; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CADHERINS; CHINA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; LUNG; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84959258285     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2015.158     Document Type: Article

References (38)

1. Murray CJ, Lopez AD. Evidence-based health policy-lessons from the Global Burden of Disease Study. Science 1996; 274: 740-3.
2. Zhong N, Wang C, Yao W, Chen P, Kang J, Huang S, et al. Prevalence of chronic obstructive pulmonary disease in China: A large, population-based survey. Am J Respir Crit Care Med 2007; 176: 753-60.
3. Decramer M, Janssens W, Miravitlles M. Chronic obstructive pulmonary disease. Lancet 2012; 379: 1341-51.
4. Rosenberg SR, Kalhan R. Biomarkers in chronic obstructive pulmonary disease. Transl Res 2012; 159: 228-37.
5. Shaw JG, Vaughan A, Dent AG, O'Hare PE, Goh F, Bowman RV, et al. Biomarkers of progression of chronic obstructive pulmonary disease (COPD). J Thorac Dis 2014; 6: 1532-47.
6. Bluher M, Mantzoros CS. From leptin to other adipokines in health and disease: Facts and expectations at the beginning of the 21st century. Metabolism 2015; 64: 131-45.
7. Carolan BJ, Kim YI, Williams AA, Kechris K, Lutz S, Reisdorph N, et al. The association of adiponectin with computed tomography phenotypes in chronic obstructive pulmonary disease. Am J Respir
8. Crit Care Med 2013; 188: 561-6.
9. Kirdar S, Ser ter M, Ceylan E, Sener AG, Kavak T, Karadag F. Adiponectin as a biomarker of systemic inflammatory response in smoker patients with stable and exacerbation phases of chronic obstructive pulmonary disease. Scand J Clin Lab Invest 2009; 69: 219-24.
10. Chan KH, Yeung SC, Yao TJ, Ip MS, Cheung AH, Chan-Yeung MM, et al. Elevated plasma adiponectin levels in patients with chronic obstructive pulmonary disease. Int J Tuberc Lung Dis 2010; 14: 1193-200.
11. Tomoda K, Yoshikawa M, Itoh T, Tamaki S, Fukuoka A, Komeda K, et al. Elevated circulating plasma adiponectin in underweight patients with COPD. Chest 2007; 132: 135-40.
12. Yoon HI, Li Y, Man SF, Tashkin D, Wise RA, Connett JE, et al. The complex relationship of serum adiponectin to COPD outcomes COPD and adiponectin. Chest 2012; 142: 893-9.
13. Yuan Y, Jiang H, Kuang J, Hou X, Feng Y, Su Z. Genetic variations in ADIPOQ gene are associated with chronic obstructive pulmonary disease. PLoS One 2012; 7: e50848.
14. Guo X, Saad MF, Langefeld CD, Williams AH, Cui J, Taylor KD, et al. Genome-wide linkage of plasma adiponectin reveals a major locus on chromosome 3q distinct from the adiponectin structural gene: The IRAS family study. Diabetes 2006; 55: 1723-30.
15. Wu Y, Li Y, Lange EM, Croteau-Chonka DC, Kuzawa CW, McDade TW, et al. Genome-wide association study for adiponectin levels in Filipino women identifies CDH13 and a novel uncommon haplotype at KNG1-ADIPOQ. Hum Mol Genet 2010; 19: 4955-64.
16. Jee SH, Sull JW, Lee JE, Shin C, Park J, Kimm H, et al. Adiponectin concentrations: A genome-wide association study. Am J Hum Genet 2010; 87: 545-52.
17. Wu Y, Gao H, Li H, Tabara Y, Nakatochi M, Chiu YF, et al. A meta-Analysis of genome-wide association studies for adiponectin levels in East Asians identifies a novel locus near WDR11-FGFR2. Hum Mol Genet 2014; 23: 1108-19.
18. Chung CM, Lin TH, Chen JW, Leu HB, Yang HC, Ho HY, et al. A genome-wide association study reveals a quantitative trait locus of adiponectin on CDH13 that predicts cardiometabolic outcomes. Diabetes 2011; 60: 2417-23.
19. Morisaki H, Yamanaka I, Iwai N, Miyamoto Y, Kokubo Y, Okamura T, et al. CDH13 gene coding T-cadherin influences variations in plasma adiponectin levels in the Japanese population. Hum Mutat 2012; 33: 402-10.
20. Hug C, Wang J, Ahmad NS, Bogan JS, Tsao TS, Lodish HF. T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. Proc Natl Acad Sci U S A 2004; 101: 10308-13.
21. Zhu M, Hug C, Kasahara DI, Johnston RA, Williams AS, Verbout NG, et al. Impact of adiponectin deficiency on pulmonary responses to acute ozone exposure in mice. Am J Respir Cell Mol Biol 2010; 43: 487-97.
22. Xu SC, Kuang JY, Liu J, Ma CL, Feng YL, Su ZG. Association between fibroblast growth factor 7 and the risk of chronic obstructive pulmonary disease. Acta Pharmacol Sin 2012; 33: 998-1003.
23. Yuan Y, Hou X, Zhang J, Chen Y, Feng Y, Su Z. Genetic variations in RORalpha are associated with chronic obstructive pulmonary disease. J Hum Genet 2014; 59: 430-6.
24. Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013; 187: 347-65.
25. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-5.
26. Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 1995; 57: 289-300.
27. Strimmer K. Fdrtool: A versatile R package for estimating local and tail area-based false discovery rates. Bioinformatics 2008; 24: 1461-2.
28. Gao H, Kim YM, Chen P, Igase M, Kawamoto R, Kim MK, et al. Genetic variation in CDH13 is associated with lower plasma adiponectin levels but greater adiponectin sensitivity in East Asian populations. Diabetes 2013; 62: 4277-83.
29. Miller M, Cho JY, Pham A, Ramsdell J, Broide DH. Adiponectin and functional adiponectin receptor 1 are expressed by airway epithelial cells in chronic obstructive pulmonary disease. J Immunol 2009; 182: 684-91.
30. Daniele A, De Rosa A, Nigro E, Scudiero O, Capasso M, Masullo M, et al. Adiponectin oligomerization state and adiponectin receptors airway expression in chronic obstructive pulmonary disease. Int J Biochem Cell Biol 2012; 44: 563-9.
31. Li Y, Yang Y, Yao Y, Li X, Shi L, Zhang Y, et al. Association study of ARL15 and CDH13 with T2DM in a Han Chinese population. Int J Med Sci 2014; 11: 522-7.
32. Hansel NN, Sidhaye V, Rafaels NM, Gao L, Gao P, Williams R, et al. Aquaporin 5 polymorphisms and rate of lung function decline in chronic obstructive pulmonary disease. PLoS One 2010; 5: e14226.
33. He JQ, Connett JE, Anthonisen NR, Pare PD, Sandford AJ. Glutathione S-Transferase variants and their interaction with smoking on lung function. Am J Respir Crit Care Med 2004; 170: 388-94.
34. Denzel MS, Scimia MC, Zumstein PM, Walsh K, Ruiz-Lozano P, Ranscht B. T-cadherin is critical for adiponectin-mediated cardioprotection in mice. J Clin Invest 2010; 120: 4342-52.
35. Korb M, Ke YB, Johnson LF. Stimulation of gene expression by introns: conversion of an inhibitory intron to a stimulatory intron by alteration of the splice donor sequence. Nucl Acids Res 1993; 21: 5901-8.
36. Cole JW, Stine OC, Liu X, Pratap A, Cheng Y, Tallon LJ, et al. Rare variants in ischemic stroke: An exome pilot study. PLoS One 2012; 7: e35591.
37. Nelson MR, Wegmann D, Ehm MG, Kessner D, St Jean P, Verzilli C, et al. An abundance of rare functional variants in 202 drug target genes sequenced in 14,002 people. Science 2012; 337: 100-4.
38. Soler Artigas M, Loth DW, Wain LV, Gharib SA, Obeidat M, Tang W, et al. Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function. Nat Genet 2011; 43: 1082-90.